DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Turpie AGG, Kreutz R, Llau J. et al.
Management consensus guidance for the use of rivaroxaban- an oral, direct factor Xa inhibitor.
Thromb Haemost 2012;
108: 876-886.
We do not assume any responsibility for the contents of the web pages of other providers.